MCCREADIE GROUP, INC.
DEXTER, MI

Elena joined McCreadie Group as Chief Operating Officer and brings excellent collaboration and strong general management skills to the role. Elena is focused on developing McGreadie Group’s organizational capabilities, to make sure our company is well positioned to grow as we continue to build on our leadership position in our target markets. Elena has over 20 years of experience leading in both global corporations (including General Electric, Coca-Cola and Delta Airlines), as well as developing smaller businesses into successful enterprises. Her areas of expertise include Strategy, Manufacturing, Operations and International Business. Elena’s work has earned her a number of professional awards, including being a two-time recipient of the President’s E Award. Elena earned her BS in Chemical Engineering from the University of Toronto and her MBA from Emory University in Atlanta, Georgia. Director of Educational Products – PharmAcademic Denise manages McCreadie Group’s Educational product, PharmAcademic. She works closely with our clients to support innovative educational processes, ensures pharmacy student and resident success, and assists with maximizing clients’ operational efficiencies using PharmAcademic. Denise received both her Doctor of Pharmacy and Master of Business Administration degrees from the University of Florida. She has extensive health systems based practice experience in informatics, operations, and administration in both the inpatient and outpatient settings. Most recently, she held a faculty position at the University of Florida College of Pharmacy and served as the Director of Experiential Programs. Additionally, Denise served as a member of the curriculum committee and taught in multiples courses relating to pharmacy informatics and health-systems practice. She has served as a preceptor to IPPE, APPE students as well as PGY1 residents. Director of Research Products – Vestigo Mike manages McCreadie Group’s Investigational Drug Service product Vestigo. Mike completed his pharmacy practice residency at the Medical College of Georgia in Augusta, Georgia and has served in technology-oriented, clinical and administrative leadership roles in pharmacy. As Director of Information Services Project Management on the hospital side of the pharmacy business, Mike served as the primary project manager for the EMR implementation at a community hospital. He has been very involved in the ASHP Section of Pharmacy Informatics and Technology in a variety of roles. Mike has been recognized as a Fellow by ASHP and has received his CPHIMS certification from HIMSS. He earned his Pharm D from Creighton University and a Master’s Certificate in Project Management from Villanova University. a four-year recipient of this honor and we are proud of our successes. If you’re looking for a career with a company that esteems innovation, technical excellence, and customer service, you will thrive at McCreadie Group. Beth Israel Deaconess Medical Center Selects McCreadie Group Investigational Drug Service Software, Vestigo® Pharmacy software solutions company helps leading academic medical center streamline workflow and regulatory compliance. McCreadie Group, Inc., a privately held pharmacy software company headquartered in Ann Arbor, Mich., announces Beth Israel Deaconess Medical Center (BIDMC) as a recent adopter of Vestigo®, the company’s web-based software for Investigational Drug Service (IDS) management. By replacing manual processes, Vestigo adds efficiencies and accuracy to the workflow of investigational drug service operations. Vestigo supports the critical need for accountability in IDS and helps ensure that complex protocols are properly managed for consistency, safety and regulatory compliance. “Top research institutions, as well as many smaller research pharmacies across the country, are recognizing the value of our secure, web-based product to structure protocols in a logical way that lends itself to safety and compliance,” said Mike Schlesselman, PharmD, director of research products for McCreadie Group. “We are thrilled to have Beth Israel Deaconess join our growing list of esteemed clients.” About McCreadie Group The McCreadie Group, Inc. was founded in 2004 to provide software solutions for pharmacy applications in healthcare, research and educational settings. The company’s goal is to drive improvements in quality, efficiency, safety and compliance in the pharmacy profession by delivering innovative software and consultative support to healthcare providers, researchers and stakeholders in pharmacy education. To learn more about McCreadie Group and its products, visit McCreadie Group will showcase Vestigo at booth 512 at HOPA’s 11th Annual Conference March 25 - 28, 2015 in Austin TX McCreadie Group will exhibit its IDS management software, Vestigo, at booth 512 at HOPA’s 11th Annual Conference. More than 900 hematology/oncology pharmacy practitioners will attend the conference at the JW Marriott in Austin, Texas March 25-28, 2015. McCreadie Group Implements Investigational Drug Service Software, Vestigo®, at Roswell Park Cancer Institute Pharmacy software solutions company helps leading cancer research institute streamline workflow and improve quality assurance. McCreadie Group, Inc., a privately held pharmacy software solutions company headquartered in Ann Arbor, Mich., announces Roswell Park Cancer Institute (RPCI) as a new user of its web-based Investigational Drug Service (IDS) software, Vestigo®. Vestigo® has set the industry standard for IDS automation by lending efficiencies to the workflow of investigational drug service operations while helping ensure that complex protocols are properly managed for consistency, safety and regulatory compliance. Launched in 2005, Vestigo® is used by many of the country’s top research institutions, as well as several smaller research pharmacies. “Vestigo® serves to help IDS comply with the HOPA Best Practice Standards in several areas, but is probably most directly relevant to its general best practice guideline of using computer software for investigational medication management,” said Mike Schlesselman, PharmD, director of research products for McCreadie Group. “Vestigo® is proving itself in 50 research hospitals and cancer centers across the country every day. We are very pleased to add Roswell Park to our rapidly growing list of prestigious clients.”